The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in uyghur population

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Cai, Wen ^a   Song, Jiang Mei ^a   Zhang, Bei ^a   Sun, Yu Ping ^a   Yao, Hua ^a   Zhang, Yue Xin ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

ADULT; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERURICEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PREVALENCE; URIC ACID BLOOD LEVEL; AGED; BLOOD; CHINA; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; HEALTH SURVEY; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTOR; YOUNG ADULT;

ADULT; AGED; CHINA; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; RISK FACTORS; URIC ACID; YOUNG ADULT;

EID: 84893164045     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/393628     Document Type: Article

References (34)

1. Lan C. H. U., Hong D., The research on the relationship between Nonalcoholic fatty liver disease and metabolic syndrome Foreign Medical Sciences 2009 36 6 383 385
2. Ryu S., Chang Y., Kim S.-G., Cho J., Guallar E., Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism 2011 60 6 860 866 2-s2.0-79956067886 10.1016/j.metabol.2010.08.005
3. Hediger M. A., Johnson R. J., Miyazaki H., Endou H., Molecular physiology of urate transport. Physiology 2005 20 2 125 133 2-s2.0-18244387733 (Pubitemid 40627553)
4. Dai X., Yuan J., Yao P., Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. European Journal of Epidemiology 2013 28 8 669 676
5. Soltani Z., Rasheed K., Kapusta D. R., Reisin E., Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Current Hypertension Reports 2013 15 3 175 181
6. Ghaemi-Oskouie F., Shi Y., The role of uric acid as an endogenous danger signal in immunity and inflammation. Current Rheumatology Reports 2011 13 2 160 166 2-s2.0-79957526145 10.1007/s11926-011-0162-1
7. Xiu-li L., Meng W., The recent advances in the pathogenesis of nonalcoholic fatty liver disease Lishzhen Medicine and Materia Medica Research 2010 21 10 2647 2648
8. Xu C., Yu C., Xu L., Miao M., Li Y., High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS ONE 2010 5 7 2-s2.0-77955366821 10.1371/journal.pone.0011578 e11578
9. Hwang I.-C., Suh S.-Y., Suh A.-R., Ahn H.-Y., The relationship between normal serum uric acid and nonalcoholic fatty liver disease. Journal of Korean Medical Science 2011 26 3 386 391 2-s2.0-79953734064 10.3346/jkms.2011.26.3.386
10. Lee J. W., Cho Y. K., Ryan M. C., Kim H., Lee S. W., Chang E., Joo K. J., Kim J. T., Kim B. S., Sung K. C., Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut and Liver 2010 4 3 378 383 2-s2.0-77957574094 10.5009/gnl.2010.4.3.378
11. Kuo C.-F., Yu K.-H., Luo S.-F., Chiu C.-T., Ko Y.-S., Hwang J.-S., Tseng W.-Y., Chang H.-C., Chen H.-W., See L.-C., Gout and risk of non-alcoholic fatty liver disease. Scandinavian Journal of Rheumatology 2010 39 6 466 471 2-s2.0-78649710412 10.3109/03009741003742797
12. Petta S., Cammà C., Cabibi D., Di Marco V., Craxì A., Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics 2011 34 7 757 766 2-s2.0-80052501527 10.1111/j.1365-2036.2011.04788.x
13. Vos M. B., Colvin R., Belt P., Molleston J. P., Murray K. F., Rosenthal P., Schwimmer J. B., Tonascia J., Unalp A., Lavine J. E., Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. Journal of Pediatric Gastroenterology and Nutrition 2012 54 1 90 96 2-s2.0-84855346047 10.1097/MPG.0b013e318229da1a
14. Kelishadi R., Cook R. S., Adibi A., Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. Journal of Pediatrics 2013 89 4 412 418
15. Sirota J. C., McFann K., Targher G., Johnson R. J., Chonchol M., Jalal D. I., Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 2013 62 3 392 399
16. Cardoso A. S., Gonzaga N. C., Medeiros C. C., Carvalho D. F., Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents. Journal of Pediatrics 2013 89 4 412 418
17. Li Y., Xu C., Yu C., Xu L., Miao M., Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. Journal of Hepatology 2009 50 5 1029 1034 2-s2.0-64549089599 10.1016/j.jhep.2008.11.021
18. Xie Y., Wang M., Zhang Y., Serum uric acid and non-alcoholic fatty liver disease in non-diabetic chinese men. PLoS One 2013 8 7 67152
19. Li N., Wang H., Yan Z., Yao X., Hong J., Zhou L., Ethnic disparties in the clustering of risk factors for cardiovascular disease among the Kazakh, Uygur, Mongolian and Han populations of Xinjiang: a cross-sectional study. BMC Public Health 2012 3 12 499 511
20. Ying X., Rongjiong Z., Jun Z., Epidemiological survey of prevalence of fatty liver and risk factors in the uyghur and han nationality patients of shuimogou district Xinjiang Medical Journal 2011 41 11 13 16
21. Yu-ying H., Aiti Y. M., Aisha A., Epidemiological survey of hyperuricemia and gout in Uygur population of Xinjiang. Journal of Chinese Practical Diagnosis and Therapy 2011 27 7 570 572
22. Workshop on fatty liver and Alcoholic Liver Disease for the Chinese Liver Disease Association, Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition Chinese Journal of Gastroenterology Hepatology 2010 19 6 483 487
23. Feig D. I., Kang D.-H., Johnson R. J., Uric acid and cardiovascular risk. The New England Journal of Medicine 2008 359 17 1811 1821 2-s2.0-54949100735 10.1056/NEJMra0800885
24. Fan J.-G., Saibara T., Chitturi S., Kim B. I., Sung J. J. Y., Chutaputti A., What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? Journal of Gastroenterology and Hepatology 2007 22 6 794 800 2-s2.0-34250332701 10.1111/j.1440-1746.2007.04952.x (Pubitemid 46911036)
25. Fan J.-G., Farrell G. C., Epidemiology of non-alcoholic fatty liver disease in China. Journal of Hepatology 2009 50 1 204 210 2-s2.0-56949097660 10.1016/j.jhep.2008.10.010
26. Ken Q., Ting Z., Qin-qin W., Study on the relevant study between non-alcoholic fatty liver disease and metabolic syndrome in Chengdu. Modern Preventive Medicine 2012 39 10 2395 2397
27. Ze-gao Z., Li X., Yue-xin Z., Analysis of the prevalence of nonalcoholic fatty liver disease in uygur civil servants in urumqi Modern Preventive Medicine 1955 39 8
28. Chang-chun C., Li W., Xiao-mei M., The survey overweight and obesity of Uyghur population above 35 years in Kashi. Chinese Journal of Epidemiology 2005 26 2, article 119
29. Shu-fen L., Xue-jun Z., Association between hyperuricemia and fatty liver. Chinese Journal of Ailerg & Cunical Immunology 2011 5 2 109 112
30. Park S. H., Kim B. I., Yun J. W., Kim J. W., Park D. I., Cho Y. K., Sung I. K., Park C. Y., Sohn C. I., Jeon W. K., Kim H., Rhee E. J., Lee W. Y., Kim S. W., Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. Journal of Gastroenterology and Hepatology 2004 19 6 694 698 2-s2.0-3042704673 10.1111/j.1440-1746.2004.03362.x (Pubitemid 38858204)
31. Dawson J., Walters M., Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? British Journal of Clinical Pharmacology 2006 62 6 633 644 2-s2.0-33751023105 10.1111/j.1365-2125. 2006.02785.x (Pubitemid 44754682)
32. García-Ruiz I., Rodríguez-Juan C., Díaz-Sanjuan T., Del Hoyo P., Colina F., Muñoz-Yagüe T., Solís-Herruzo J. A., Uric acid and anti-TNF antibody improve mitochondrial dysfunction in ob/ob mice. Hepatology 2006 44 3 581 591 2-s2.0-33748946183 10.1002/hep.21313 (Pubitemid 44433714)
33. Hayden M. R., Tyagi S. C., Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutrition and Metabolism 2004 1 1 1 15 2-s2.0-13144253218 10.1186/1743-7075-1-10 (Pubitemid 40397801)
34. Patterson R. A., Horsley E. T. M., Leake D. S., Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid. Journal of Lipid Research 2003 44 3 512 521 2-s2.0-0038243183 10.1194/jlr.M200407-JLR200 (Pubitemid 37279698)